-
16
-
[转载]Yervoy(易普利姆玛ipilimumab)注射液使用说明书.docx
- [转载]Yervoy(易普利姆玛ipilimumab)注射液使用说明书原文地址：Yervoy(易普利姆玛ipilimumab)注射液使用说明书2011年3月第一版作者：tangzhongmingYer
-
-
11
-
Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma_2-year overall survival outcomes in a multicentre, rando.pdf
- Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma_2-year overall survival outcomes in a multicentre, randoin,a,vs,and,with,alone,Alone,With
-
-
11
-
Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012) results of an open-label, phase 1, multicohort study.pdf
- /oncologyVol 18 January 2017 31ArticlesNivolumab plus ipilimumab rst-linetreatment
-
-
2
-
Safety and Efficacy of First-Line Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) and Ipilimumab in Non-Small Cell Lung Cancer (NSCLC) Metastatic Non-Small Cell Lung Cancer.pdf
- AESIreported arm(Any Gr: 1.5% vs 2.0%;Gr 0.4%vs GC+Npts continuing single-agent meannumber 6.4(media
-
-
120
-
Ipilimumab amp; Vemurafenib - univ-lille2.fr.ppt
- Ipilimumab
-
-
33
-
Yervoy(ipilimumab)用于治疗不可切除(转移性)黑色素瘤.pdf
- Yervoy(ipilimumab)用于治疗不可切除(转移性)黑色素瘤Yervoy(ipilimumab)用于治疗不可切除(转移性)黑色素瘤Yervoy(ipilimumab)用于治疗不可切除(转移性)黑色素瘤
-
-
13
-
A Randomized Phase II Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab in Patients with Advanced Gastrointestinal Stromal Tumors.pdf
- A Randomized Phase II Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab in Patients with Advanced Gastrointestinal Stromal TumorsA Randomized Phase II Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab in Patients with Advanced Gastrointestinal Stromal TumorsA Randomized Phase II Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab in Patients with Advanced Gastrointestinal Stromal Tumors
-
-
10
-
response to ipilimumab therapy in metastatic melanoma patients_ potential relevance of ctla-4( ) tumor infiltrating lymphocytes and their in situ l.pdf
- response to ipilimumab therapy in metastatic melanoma patients_ potential relevance of ctla-4( ) tumor infiltrating lymphocytes and their in situ l
-
-
13
-
Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006) post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study.pdf
- Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006) post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study
-
-
13
-
Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo) a multicentre, phase 2, randomised, cont...pdf
- Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo) a multicentre, phase 2, randomised, controlled trial
-
向豆丁求助：有没有Ipilimumab?
33
13
10
13
13
